2019
DOI: 10.3892/etm.2019.7510
|View full text |Cite
|
Sign up to set email alerts
|

Multi‑walled carbon nanotube‑based systems for improving the controlled release of insoluble drug dipyridamole

Abstract: Applicability of multi-walled carbon nanotubes (MWCNTs) in loading dipyridamole (DDM), a poorly soluble drug, was evaluated. Additionally, the effect of drug-loading efficiency on the release behavior of the MWCNT-DDM system was also investigated. DDM as a model drug was incorporated into MWCNTs with different drug-loading rates (10, 25 and 50%) using the solvent deposition method. The MWCNT-DDM system was successfully established and characterized using common solid-state characterization methods. Scanning el… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
14
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(15 citation statements)
references
References 37 publications
1
14
0
Order By: Relevance
“…All tests were conducted in PBS (pH 6.8–7.4) as the dissolution media for the drug release study. Samples Drug loaded Maximum drug released (%) Overall time released (min) Ref MWCNT-COOH/gelatin-CHI MWCNT-PEG/gelatin-CHI Ciprofloxacin lactate (10 μg) 97.5 98.1 90 48 MWCNT Dipyridamole (50 wt%) 40.0 60 51 MWCNT-COOH Griseofulvin Sulfamethoxazole (N/A) 80.0 80.0 120 52.5 52 MWCNT-PEG Methotrexate (56.5 wt%) 44.2 1680 53 MWCNT-COOH 6 mercaptopurine (65 wt%) 96.1 1200 54 MWCNT-glucose/starch Zolpidem (75 wt%) 64.0 4320 55 …”
Section: Resultsmentioning
confidence: 99%
“…All tests were conducted in PBS (pH 6.8–7.4) as the dissolution media for the drug release study. Samples Drug loaded Maximum drug released (%) Overall time released (min) Ref MWCNT-COOH/gelatin-CHI MWCNT-PEG/gelatin-CHI Ciprofloxacin lactate (10 μg) 97.5 98.1 90 48 MWCNT Dipyridamole (50 wt%) 40.0 60 51 MWCNT-COOH Griseofulvin Sulfamethoxazole (N/A) 80.0 80.0 120 52.5 52 MWCNT-PEG Methotrexate (56.5 wt%) 44.2 1680 53 MWCNT-COOH 6 mercaptopurine (65 wt%) 96.1 1200 54 MWCNT-glucose/starch Zolpidem (75 wt%) 64.0 4320 55 …”
Section: Resultsmentioning
confidence: 99%
“…Dipyridamole-loaded MWCNTs showed an increased drug dissolution rate, which decreased with increases in the drug-loading rate of carriers. Moreover, with increasing drug loading, the dipyridamole in the MWCNTs changed its form from an amorphous to a crystalline state [ 105 ]. Bisphosphonate (alendronic, neridronic and pamidronic acids, see Figure 9 )-conjugated MWCNTs showed pH-dependent drug release, which was faster at lower pH values.…”
Section: Carbon Nanotubesmentioning
confidence: 99%
“…Considerable efforts have been made in the last decade to explore the biomedical use of graphene-based nanomaterials and carbon nanotubes, especially in the intelligent administration of anticancer drugs [ 26 , 104 , 105 ]. Unfortunately, regulatory authorities have not approved a single product for launching to the market where these carbon-based nanomaterials are used.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[ 10–12 ] For example, this carrier was used in order to improve the controlled release of insoluble drug dipyridamole. [ 13 ] Therefore, in the current study, we will use the MWCNT as an adsorbent for drug molecule.…”
Section: Introductionmentioning
confidence: 99%